{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Diana+Johnson&answer.dateOfAnswer=2019-06-11", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Diana+Johnson&answer.dateOfAnswer=2019-06-11", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Diana+Johnson&answer.dateOfAnswer=2019-06-11&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Diana+Johnson&_page=0&answer.dateOfAnswer=2019-06-11", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Diana+Johnson&answer.dateOfAnswer=2019-06-11", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Diana+Johnson&answer.dateOfAnswer=2019-06-11", "items" : [{"_about" : "http://data.parliament.uk/resources/1129387", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1129387/answer", "answerText" : {"_value" : "
Public Health England (PHE) undertakes comprehensive surveillance through the gonococcal resistance to antimicrobials surveillance programme (GRASP) to enable early detection and management of antibiotic resistance in gonorrhoea and uses this intelligence to advise on national gonorrhoea treatment guidelines and ensure they remain effective. PHE also investigates outbreaks and individual cases of extensively drug resistant gonorrhoea and potential treatment failures to ensure effective management and control spread. Further information can be found at the following link:<\/p>